A
Accolade
A personalized health and benefits solution that dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members
At a glance
- Founded
- 2007
- Headquarters
- Plymouth Township, United States
- Listing
- IPO 2020
- Sector
- Health Tech & Medtech
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Research & analysis
Latest news
Press, funding announcements and product moves mentioning Accolade.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- HUHumana
- ACAccretive
Series B and later5 investors entered at this stage
Andreessen Horowitz- CPCarrick Capital Partners
Madrona Venture Group- MVMcKesson Ventures
Comcast Ventures
Source: Dealroom Talent Intelligence.
Alumni founders
Former Accolade employees who went on to found companies, sorted by Dealroom signal score.
DUDUOSEst. 2021
Anne Marie AponteUnited States
CACareBridgeEst. 2019
Bill FristUnited States
Rajeev SinghUnited States
HHHerself HealthEst. 2022
Michael ClineUnited StatesGlobal footprint
team presence
across markets
Patents
6 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Accolade was the backer or acquirer, 2019–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Accolade's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Accolade deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Accolade's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Accolade on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Accolade on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.